
This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

I'm PortAI, I can summarize articles.
Top Wall Street analysts have initiated coverage on several companies with bullish ratings. HC Wainwright & Co. gave American Bitcoin Corp (ABTC) a Buy rating with a $4 price target. Ascendiant Capital rated Synergy CHC Corp. (SNYR) as Buy with a $5 target. Wells Fargo rated Praxis Precision Medicines (PRAX) as Equal-Weight with a $282 target. Guggenheim rated Avalo Therapeutics (AVTX) as Buy with a $50 target, while Rapport Therapeutics (RAPP) received an Overweight rating and a $43 target from Wells Fargo.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

